For Shareholders
This section is dedicated for publication of information relevant to our shareholders.
Shareholders are welcome to contact Captor Therapeutics by e-mail address: captortherapeutics.com or by phone +48 690 800 678.
COMPANY REGISTRATION DATA:
NAME: | CAPTOR THERAPEUTICS SPÓŁKA AKCYJNA |
|
ADRESS: | 54-427 WROCŁAW UL. DUŃSKA 11 | |
PHONE NUMBER: | +48 537 869 089 | |
WEBSITE: | ||
E-MAIL: | ||
REGON: | 363381765 | |
VAT: | PL8943071259 | |
KRS: | 0000756383 | |
District Court for Wrocław-Fabryczna in Wrocław, VI Commercial Division of the National Court Register | ||
SHARE CAPITAL: | PLN 359 000,00 fully paid |
Captor Therapeutics was founded on 19 November 2015 and registered at the National Court Register (KRS) on 30 December 2015, as a limited company.
On 7 November 2018 Captor Therapeutics was transformed into an incorporated company.
NEWS RELEASES:
12.01.2021
Fifth call to submit share documents
11.12.2020
Fourth call to submit share documents
9.11.2020
Third call to submit share documents
16.10.2020
Second call to submit share documents
30.09.2020
First call to submit share documents
30.09.2020
The Management Board of Captor Therapeutics S.A., with its registered office in Wrocław, informs that according to the resolution of the Annual General Meeting dated 28.06.2020, the register of shareholders will be kept by Trigon Dom Maklerski S.A.